Category: Uncategorized

Hyloris Announces Alenura® Positive IDMC Results

March 19, 2025

The Independent Data Monitoring Committee (IDMC) Recommends Continuation of the Alenura Clinical Trial Following Interim Assessment. Read full Press Release.

Vaneltix Starts New Multiple Dose Clinical Trial

December 14, 2024

December 14, 2024, New Brunswick, NJ – Vaneltix Pharma, Inc. (“Vaneltix” or “the Company”), a specialty pharmaceutical company focused on…

Vaneltix planning to enroll subjects in new round of clinical trials

February 21, 2023

On Tuesday, February 21st 2023, Bound Brook, NJ – Vaneltix Pharma, Inc. (Formerly Urigen Pharmaceuticals, Inc.; “Vaneltix” or “the Company”),…